Skip to main content
. 2014 Aug 28;29(5):558–570. doi: 10.3904/kjim.2014.29.5.558

Figure 2.

Figure 2

Cumulative probability of medication use and surgery in Korean patients with Crohn disease. (A) 5-aminosalicylates (5-ASA), (B) thiopurines, (C) anti-tumor necrosis factor (anti-TNF) agents, and (D) intestinal resection. Adapted from Ye et al. [19] 9th Congress of European Crohn's and Colitis Organization.